303 related articles for article (PubMed ID: 1607702)
1. Absence of human T cell lymphotrophic virus (HTLV) type I and II DNA in French anti-HTLV-I/II-negative intravenous drug users.
Lefrère F; Wattel E; Mariotti M; Agis F; Gordien E; Lefrère JJ
J Infect Dis; 1992 Jul; 166(1):212-3. PubMed ID: 1607702
[No Abstract] [Full Text] [Related]
2. [HTLV-I and HTLV-II viruses: fifteen years after their description].
Delaporte E
Med Trop (Mars); 1995; 55(1):17-20. PubMed ID: 7637602
[No Abstract] [Full Text] [Related]
3. Human T-cell lymphotrophic virus in California's injection drug users.
Trachtenberg AI; Gaudino JA; Hanson CV
J Psychoactive Drugs; 1991; 23(2):225-32. PubMed ID: 1765894
[TBL] [Abstract][Full Text] [Related]
4. HTLV infection among Italian intravenous drug users and North African subjects detected by the polymerase chain reaction and serological methods.
Colombo E; Magistrelli C; Mendozzi E; Cattaneo E; Achilli G; Ferrante P
J Med Virol; 1995 Sep; 47(1):10-5. PubMed ID: 8551251
[TBL] [Abstract][Full Text] [Related]
5. Detection and characterization of human T-lymphotropic viruses.
Calabrò ML; Favero A; Chieco-Bianchi L
Antibiot Chemother (1971); 1994; 46():125-33. PubMed ID: 7826033
[No Abstract] [Full Text] [Related]
6. [Confirmation of the presence in Cuba of human T-cell lymphotropic virus type I using the polymerase chain reaction].
Rolo Gómez F; De Armas MB; Mato Luis J; Lubián Caballero AL; Díaz Torres H
Rev Cubana Med Trop; 1997; 49(3):204-8. PubMed ID: 9685988
[TBL] [Abstract][Full Text] [Related]
7. Laboratory study of HIV-1 and HTLV-I/II coinfection.
Beilke MA; Greenspan DL; Impey A; Thompson J; Didier PJ
J Med Virol; 1994 Oct; 44(2):132-43. PubMed ID: 7852953
[TBL] [Abstract][Full Text] [Related]
8. Detection of HTLV-II proviral sequences in HIV-immunosuppressed patients with HTLV indeterminate serological patterns.
Soriano V; Gutiérrez M; González-Lahoz J
J Infect; 1998 Mar; 36(2):243-4. PubMed ID: 9570669
[No Abstract] [Full Text] [Related]
9. Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: a new association with intravenous drug abuse.
Kaplan MH; Sadick NS; McNutt NS; Talmor M; Coronesi M; Hall WW
J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):701-8. PubMed ID: 8227542
[TBL] [Abstract][Full Text] [Related]
10. Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.
Jõgeda EL; Avi R; Pauskar M; Kallas E; Karki T; Des Jarlais D; Uusküla A; Lutsar I; Huik K
Infect Genet Evol; 2016 Sep; 43():83-5. PubMed ID: 27223634
[TBL] [Abstract][Full Text] [Related]
11. HTLV-1/2 among high-risk groups in Argentina: molecular diagnosis and prevalence of different sexual transmitted infections.
Berini CA; Pando MA; Bautista CT; Eirin ME; Martinez-Peralta L; Weissenbacher M; Avila MM; Biglione MM
J Med Virol; 2007 Dec; 79(12):1914-20. PubMed ID: 17935172
[TBL] [Abstract][Full Text] [Related]
12. The role of human T-cell lymphotropic viruses (HTLV-I and II) in cutaneous T-cell lymphomas.
Zucker-Franklin D; Pancake BA
Semin Dermatol; 1994 Sep; 13(3):160-5. PubMed ID: 7986683
[TBL] [Abstract][Full Text] [Related]
13. Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?
Khabbaz RF; Hartel D; Lairmore M; Horsburgh CR; Schoenbaum EE; Roberts B; Hartley TM; Friedland G
J Infect Dis; 1991 Feb; 163(2):252-6. PubMed ID: 1988509
[TBL] [Abstract][Full Text] [Related]
14. Making the invisible visible: searching for human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in Brazilian patients with viral hepatitis B and C.
Caterino-de-Araujo A; Alves FA; Campos KR; Lemos MF; Moreira RC
Mem Inst Oswaldo Cruz; 2018 Feb; 113(2):130-134. PubMed ID: 29236927
[TBL] [Abstract][Full Text] [Related]
15. Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/II-seropositive blood donors of the French West Indies.
Wattel E; Mariotti M; Agis F; Gordien E; Prou O; Courouce AM; Rouger P; Wain-Hobson S; Chen IS; Lefrère JJ
J Infect Dis; 1992 Feb; 165(2):369-72. PubMed ID: 1730903
[TBL] [Abstract][Full Text] [Related]
16. Human T-cell lymphotropic virus types I and II infections in patients with leukaemia/lymphoma and in subjects with sexually transmitted diseases in Nigeria.
Olaleye OD; Ekweozor CC; Li ZL; Opala IE; Sheng Z; Onyemenem TN; Rasheed S
Arch Virol; 1996; 141(2):345-55. PubMed ID: 8634025
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
Casoli C; Pilotti E; Bertazzoni U
AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
[TBL] [Abstract][Full Text] [Related]
18. Lack of evidence for human T cell lymphotrophic virus type I or II infection in patients with systemic lupus erythematosus or rheumatoid arthritis.
Bailer RT; Lazo A; Harisdangkul V; Ehrlich GD; Gray LS; Whisler RL; Blakeslee JR
J Rheumatol; 1994 Dec; 21(12):2217-24. PubMed ID: 7535355
[TBL] [Abstract][Full Text] [Related]
19. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
20. HTLV infection in ELISA-negative blood donors.
Zehender G; Girotto M; De Maddalena C; Francisco G; Moroni M; Galli M
AIDS Res Hum Retroviruses; 1996 May; 12(8):737-40. PubMed ID: 8744584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
